EstimizeAlerts,,2019-02-11 12:02:00,119.97,ALXN analysts on Estimize are expecting 2289 YoY revenue growth for Q1 down from 2411 in Q4 Reporting 0425 BMOestimizecomintroalxncha
cctranscripts,,2019-02-11 10:44:00,120.103,The Vanguard Group just provided an update on share ownership of Alexion Pharmaceuticals conferencecalltranscriptso ALXN
risenhoover,,2019-02-11 10:38:00,120.287,Vanguard Group Inc has filed an amended 13GA reporting 727 ownership in ALXN httpsfinteliosousalxn
livetraderalerts,,2019-02-11 10:32:00,120.255,ALXN 19m ago SEC Amended Beneficial Ownership Report SC 13GA ALEXION PHARMACEUTICALS INC secgovArchivesedgardata
